Through our 'Adding Value In Research' framework
we do everything we can to ensure that our research answers the most pressing questions and that our findings are widely disseminated and usable. We partner with the National Institute for Health and Care Excellence (NICE), whose influential guidelines almost invariably cite our evidence, and with organisations that are responsible for the adoption and diffusion of innovation such as the Academic Health Science Networks.
We also make an important economic contribution. In 2018-19, our research infrastructure supported more than 3,600 studies with industry and more than 1,500 collaborations and partnerships with small and medium-sized businesses. According to a report by KPMG
, clinical research activity supported by our Clinical Research Network in 2018-19 generated £2.7 billion of gross value added and created an estimated 47,500 jobs.
We have research programmes that provide evidence intended to make the health and care system more efficient and therefore sustainable. For example, our Health Services and Delivery Research programme
funds research into the quality, accessibility and organisation of health and social care services, and the Evidence Synthesis programme
that supports the production of evidence to help inform the production of clinical guidelines. We also help the health and care system to save money by identifying ineffective practices, and by helping people stay healthy, we also help them stay in work and contributing to the economy.
Our work in global health
is also starting to demonstrate an impact on health and wealth in low and middle income countries.
More information about our impact on health and wealth is published in the 2016 RAND report
, which was commissioned to mark 10 years of the NIHR. This identifies 100 examples of positive change resulting from NIHR's support of research. Our annual reports
provide data on our impact as well as examples of key milestones.